SS

Salooj Sreelatha Rajan

Active Director Designated Partner DIN 09298501
DIN 09298501 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Salooj Sreelatha Rajan

Data last updated:

Salooj Sreelatha Rajan is a Designated Partner at Papyrus Pharmaceutical Llp (since 2021). The company operates in Pharma.

DIN 09298501
Primary Designation Designated Partner
Industry Pharma
First Appointment 29 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Aug 20212021Active

Board colleagues of Salooj Sreelatha Rajan

NameDINCompanyDesignation
Rarichan Kandy Muhammad Suhaj09298502Papyrus Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Papyrus Pharmaceutical Llp
Premium access

Shareholding and investment profile for Salooj Sreelatha Rajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Salooj Sreelatha Rajan

Salooj Sreelatha Rajan currently holds 1 directorship: Papyrus Pharmaceutical Llp (Designated Partner, since 29 Aug 2021).

Salooj Sreelatha Rajan was first appointed on 29 Aug 2021 as Designated Partner at Papyrus Pharmaceutical Llp.

The current boards of Salooj Sreelatha Rajan's companies include Rarichan Kandy Muhammad Suhaj (Papyrus Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available